FindTrial
Sign In

Neuromodulation in patients undergoing hemodialysis

Transcranial Direct Current Stimulation for pain and functionality in patients undergoing Hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-46vhrkj
Enrollment
Unknown
Registered
2022-04-04
Start date
2018-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Interventions

The study will present 5 phases: (1) initial meeting with patients to measure pain levels, mood states and functionality
(2) share of patients into two groups, each containing 15 members, being distributed according to the type of stimulation: motor area M1 and sham (3) the application of ten sessions of transcranial di
(4) a reassessment on the last day of transcranial direct current stimulation application (10th day)
(5) reassessment with one week after completion of treatment (follow-up 1), (6) re-evaluation at 1 month after completion of treatment. This study was conducted at the Federal University of Rio Grande
E02.331.750

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 75 years; previous medical evaluation with clinical diagnosis of depression, anxiety, chronic pain and pressure lability and being on hemodialysis treatment

Exclusion criteria

Exclusion criteria: Evidence of any cognitive deficit (senile dementia, Alzheimer's); presence of physical and / or organic difficulties; individuals with severe cardiovascular risk or hemodynamically unstable; history of seizures or epileptic disease; pregnancy; metallic implants in the head or neck and cardiac pacemaker.

Design outcomes

Primary

MeasureTime frame
Moderate pain improvement verified by a 30% decrease in the visual analog pain scale in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).—

Secondary

MeasureTime frame
Secondary 1: Depression improvement accornding to moderate (50% of improvement) decrease scores of the Beck depression inventory in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).;Secondary 2: Improvement of 30% or more in anxiety symptom verified by the reduction of the Hamilton Anxiety Questionnaire in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).;Secondary 3: Clinically functionality improvement verified through decrease of more than 5 points the Kidney Disease Quality of Life questionnaire in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).—

Countries

Brazil

Contacts

Public ContactRodrigo Pegado de Freitas

Universidade Federal do Rio Grande do Norte

rodrigopegado@gmail.com+5584999150043

Outcome results

None listed

Source: REBEC (via WHO ICTRP)